Table 1.
Anti-PLA2R expression in tissue and anti-PLA2R fluorescence intensity in blood.
| Group | Anti-PLA2R expression in tissue | Anti-PLA2R fluorescence intensity in blood | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| − | ± | + | ++ | +++ | − | ± | + | ++ | +++ | |
| Stage I (20) | 6 | 6 | 8 | 0 | 0 | 5 | 6 | 9 | 0 | 0 |
| Stage II (20) | 2 | 1 | 1 | 8 | 8 | 1 | 0 | 2 | 9 | 8 |
| Stage III (20) | 2 | 0 | 1 | 8 | 9 | 2 | 0 | 1 | 9 | 8 |
| Stage IV (20) | 6 | 6 | 8 | 0 | 0 | 5 | 6 | 9 | 0 | 0 |
| Stage V (20) | 8 | 8 | 4 | 0 | 0 | 8 | 9 | 3 | 0 | 0 |
| Control group (20) | 19 | 0 | 1 | 0 | 0 | 19 | 0 | 1 | 0 | 0 |
| Normal group (20) | — | — | — | — | — | 20 | 0 | 0 | 0 | 0 |
| Total | 43 | 21 | 21 | 21 | 21 | 60 | 21 | 25 | 25 | 16 |